CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-356
Published Online: 2014-05-21
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Incoronato, Mariarosaria
Mirabelli, Peppino
Catalano, Onofrio
Aiello, Marco
Parente, Chiara
Soricelli, Andrea
Nicolai, Emanuele
License valid from 2014-05-21